@ESICM Bayesian is not easy to do
- need technical expertise
- need specific software
- and deals with "subjectivism" which doesnt go down well with "scientific thinking"
@ESICM e.g., 400 pts randomised to Rx v placebo
- 50/200 (25%) died in Rx
- 65/200 in control
- negative 7.5% risk difference.
Frequentist confidence interval (not statistically significant) 95% CI overlaps null. so p-value is 0.09.
if you do a Bayesian analysis without any prior being set. using fancy analysis you got the exactly same Bayesian credible interval.
So bayesian analysis if you dont incorporate "any prior beliefs" ,its effectively identical to frequentist approach.
Bayesian is all about "prior belief". it is an old technique develooed in 19th century before even p-values come about.
So now with knowing a prior distribution.
If you then hve a different prior distributor then the posterior distribution becomes narrower.
That is a very important difference but most of the people don't care.
Normal people dont care and most clinical colleagues doesnt matter.
But lets put aside philosophical differences.
Why do we go "Bayesian" 1. design flexibility. makes platform trials possible
and you would interpret Confint as per frequentist if ya dont include any prior. e.g., in above IL6 trial
2. to incorporate prior distribution
e.g., in EOLIA trial (Goligher paper above)
you can use non-belief based prior and obtain meta-analytical prior.
already 2 good reasons . There is 3rd. 3. "because you like it". it is more intuitive way of thinking probability.
Poor reasons for going Bayesian : 1. expecting better results
no difference in effect estimate precision, no difference in sample size
or because it is hot
Poor reason for going Baysian "as a smoke screen for design flaws". Bayesian approaches handle missing data better. But if your missing data is not random i.e., meaningful missingness -> then it will add nothing.
Q: how "involved" is it to do Bayesian analysis?
A: there is a point and click SPSS style interface. but will require weeks of training to be able to quality control properly.
Q: how to best choose a "prior" ?
A: no good answer as he doesnt think this is a best route to analysing it.
Mariangela PELLEGRINI
Uppsala- Sweden
"Do we Need a biological definition of ARDS"
- Berlin definition has NO Diffuse alveolar damage .
- the Berlin defn does not capture well
Frohlich - different definitions specificity of 0.63, 0.42, 0.31 even! #ventilation#ards#LIVES2022
ARDS - new definition or phenotypes by @GicoBellani refreshing with Kigali definition of ARDS - useful not just low resource but during pandemic in supposedly high income settings and only draw back is no PEEp requirement #ards#ventilation#LIVES2022@ESICM
@GicoBellani@ESICM Resolved versus confirmed ARDS
- prospectively applying Berlin definition did work but if ya wait 24 hrs and re-measure P/F ratio, you end up stratifying much better.
- Better separation of groups
NEXT Speaker : VA ecmo for which patients?
Alain COMBES
Severe cardiogenic shock has different phenotypes 1. medical cardiogenic shock(AMI, end stage dilated CM, myocarditis, septic shock) 2. Post cardiotomy refractory CS (post CABG) #LIVES2022 @ESICM#ecmo#resuscitation#ALS
@ESICM 2022 what do the guidelines say
- ESC recommends short term MCS should be considred in cardiogenic shock.
IABP may be considered but not routinely recommended in post MI #LIVES2022